Bone Marrow Transplant (BMT)
Show Only Open Trials
1.
BMT CTN 0701: A Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response
- Study Status: Open to Enrollment
- Sponsor: National Heart, Lung and Blood Institute (NHLBI); National Cancer Institute
- Disease Status and/or Stage: Relapsed Follicular Non-Hodgkin's Lymphoma
2.
Lenalidomide plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
- Study Status: Open to Enrollment
- Disease Status and/or Stage: Multiple Myeloma
